April 16, 2025
Pre-exposure prophylaxis (PrEP) for HIV is a highly effective tool for preventing HIV transmission in all populations and countries. However, despite being approved and available by […]
April 8, 2025
According to a study published in The Lancet HIV, recent and planned international budget cuts could result in 4.4-10.8 million new HIV infections by 2030 in […]
April 8, 2025
The latest federal funding cuts are already affecting progress against HIV, according to a panel of experts at a briefing hosted by the Infectious Diseases Society […]
March 31, 2025
TOPLINE: The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine was safe and well tolerated and offered protection against mpox in people living with HIV, individuals on HIV […]
March 27, 2025
TOPLINE: Switching from a boosted protease inhibitor (bPI)–based regimen to bictegravir plus emtricitabine plus tenofovir alafenamide (B/F/TAF) maintained virological suppression over 48 weeks in patients with […]
March 24, 2025
GENEVA (Reuters) -There could be 2,000 new HIV infections a day across the world and a ten-fold increase in related deaths if funding frozen by the […]
March 20, 2025
The double dosing of dolutegravir and bictegravir HIV regimens in combination with rifampicin-based therapies for tuberculosis (TB) in people living with HIV showed similarly low levels […]
March 19, 2025
Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), based on data from 108 individuals. Previous research has […]
March 17, 2025
TOPLINE: Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. METHODOLOGY: Researchers conducted a randomized, […]